294 related articles for article (PubMed ID: 29040872)
21. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
Yagi H; Matsumoto M; Fujimura Y
Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
[TBL] [Abstract][Full Text] [Related]
22. Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura.
Deforche L; Tersteeg C; Roose E; Vandenbulcke A; Vandeputte N; Pareyn I; De Cock E; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
PLoS One; 2016; 11(8):e0160388. PubMed ID: 27479501
[TBL] [Abstract][Full Text] [Related]
23. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.
Hulstein JJ; de Groot PG; Silence K; Veyradier A; Fijnheer R; Lenting PJ
Blood; 2005 Nov; 106(9):3035-42. PubMed ID: 16014562
[TBL] [Abstract][Full Text] [Related]
24. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
Rank CU; Kremer Hovinga J; Taleghani MM; Lämmle B; Gøtze JP; Nielsen OJ
Eur J Haematol; 2014 Feb; 92(2):168-71. PubMed ID: 24033710
[TBL] [Abstract][Full Text] [Related]
25. Shear stress and von Willebrand factor in health and disease.
Tsai HM
Semin Thromb Hemost; 2003 Oct; 29(5):479-88. PubMed ID: 14631548
[TBL] [Abstract][Full Text] [Related]
26. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.
Motto DG; Chauhan AK; Zhu G; Homeister J; Lamb CB; Desch KC; Zhang W; Tsai HM; Wagner DD; Ginsburg D
J Clin Invest; 2005 Oct; 115(10):2752-61. PubMed ID: 16200209
[TBL] [Abstract][Full Text] [Related]
27. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
George JN
Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
[TBL] [Abstract][Full Text] [Related]
28. [Treatment strategy for patients with thrombotic thrombocytopenic purpura].
Yagi H
Rinsho Ketsueki; 2021; 62(8):1222-1228. PubMed ID: 34497210
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13.
Chrisentery-Singleton T; Boggio LN; Carcao MD; Ibrahimi S; Khan O; Mahajerin A; Rajasekhar A; Sharma V; Steele M; Torres M; Rodino FJ; Carpenter SL
Haemophilia; 2023 Nov; 29(6):1638-1645. PubMed ID: 37855744
[TBL] [Abstract][Full Text] [Related]
30. Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke.
McCabe DJ; Murphy SJ; Starke R; Harrison P; Brown MM; Sidhu PS; Mackie IJ; Scully M; Machin SJ
J Neurol Sci; 2015 Jan; 348(1-2):35-40. PubMed ID: 25498844
[TBL] [Abstract][Full Text] [Related]
31. High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13.
Kragh T; Napoleone M; Fallah MA; Gritsch H; Schneider MF; Reininger AJ
Thromb Res; 2014 Jun; 133(6):1079-87. PubMed ID: 24681085
[TBL] [Abstract][Full Text] [Related]
32. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
Bao J; Xiao J; Mao Y; Zheng XL
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
[TBL] [Abstract][Full Text] [Related]
33. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.
Bonnefoy A; Daenens K; Feys HB; De Vos R; Vandervoort P; Vermylen J; Lawler J; Hoylaerts MF
Blood; 2006 Feb; 107(3):955-64. PubMed ID: 16204318
[TBL] [Abstract][Full Text] [Related]
34. Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.
Geys L; Roose E; Scroyen I; Rottensteiner H; Tersteeg C; Hoylaerts MF; Vanhoorelbeke K; Lijnen HR
J Thromb Haemost; 2018 Jan; 16(1):150-163. PubMed ID: 29121438
[TBL] [Abstract][Full Text] [Related]
35. Linear relationship between ADAMTS13 activity and platelet dynamics even before severe thrombocytopenia.
Song J; Lee KA; Park TS; Park R; Choi JR
Ann Clin Lab Sci; 2008; 38(4):368-75. PubMed ID: 18988930
[TBL] [Abstract][Full Text] [Related]
36. Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.
Joly BS; Darmon M; Dekimpe C; Dupont T; Dumas G; Yvin E; Beranger N; Vanhoorelbeke K; Azoulay E; Veyradier A
J Thromb Haemost; 2021 Sep; 19(9):2193-2198. PubMed ID: 34219357
[TBL] [Abstract][Full Text] [Related]
37. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
Schiphorst RH; van de Kar NC; van den Heuvel LP
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
[TBL] [Abstract][Full Text] [Related]
38. Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.
Sorvillo N; Mizurini DM; Coxon C; Martinod K; Tilvawala R; Cherpokova D; Salinger AJ; Seward RJ; Staudinger C; Weerapana E; Shapiro NI; Costello CE; Thompson PR; Wagner DD
Circ Res; 2019 Aug; 125(5):507-519. PubMed ID: 31248335
[TBL] [Abstract][Full Text] [Related]
39. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.
Peyvandi F; Siboni SM; Lambertenghi Deliliers D; Lavoretano S; De Fazio N; Moroni B; Lambertenghi Deliliers G; Mannuccio Mannucci P
Br J Haematol; 2006 Jul; 134(2):187-95. PubMed ID: 16846477
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons.
Feys HB; Roodt J; Vandeputte N; Pareyn I; Mottl H; Hou S; Lamprecht S; Van Rensburg WJ; Deckmyn H; Vanhoorelbeke K
Blood; 2012 Oct; 120(17):3611-4. PubMed ID: 22855603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
